Serum CEA serves as a representative tumor marker and is known to be elevated in various solid tumors, including colorectal cancer, gastric cancer, pancreatic cancer, pulmonary cancer, breast cancer and head and neck cancer. This evidence concerns the gene CEACAM5 and gastric cancer.